Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
immune globulin (human) (Gamastan) (1 trial)
COVID-19 convalescent plasma (2 trials)
Unverricht-Lundborg Syndrome (Phase 3)
Trials (3 total)
Trial APIs (2 total)